SCHEMBL3165698

SCHEMBL3165698

CC(C)(C)OC(=O)N(C(=O)C1CCCN1)C(Cc1ccccc1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTSC P53634 2/20 0.43
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
HTR2C P28335 2/20 0.40
HTR2B P41595 1/20 0.40
SCN4A P35499 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
GHSR Q92847 2/20 0.36
SLC6A4 P31645 1/20 0.35
TSHR P16473 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
ACE P12821 1/20 0.35
YAP1 P46937 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27735771 0.83 ITGB3 (0.45) CTSCITGB3ITGA2BHTR2CHTR2B
SCHEMBL5163365 0.81 ITGA4 (0.42) CTSCSCN4A
SCHEMBL9321962 0.80 ATM (0.45) L3MBTL1CYP1A2ACE
SCHEMBL8392929 0.80 ATM (0.45) L3MBTL1CYP1A2ACE
SCHEMBL11651226 0.80 ATM (0.45) L3MBTL1CYP1A2ACE
SCHEMBL31593391 0.79 CTSC (0.40) CTSCITGB3ITGA2BHTR2CHTR2B
SCHEMBL10790231 0.79 CTSC (0.40) CTSCHTR2CHTR2BL3MBTL1GHSR
SCHEMBL28958862 0.78 ATM (0.43) L3MBTL1CYP1A2ACE
SCHEMBL27514790 0.78 ITGB3 (0.33) ITGB3ITGA2BSCN4A
SCHEMBL27565204 0.77 CTSC (0.47) CTSCHTR2CHTR2BSCN4AGHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817109-B1 MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL MERCK PATENT GMBH (DE) 2020-02-26 EP disclosed
US-7648636-B2 A chromatographic support including an immobilized ligand which combines an anion-exchange domain comprising an oligocyclic aza compound with endocyclic nitrogen and a non-ionic, second binding domain to allow adjustment of the overall hydrophobicity/hydrophilicity; separation; purification; peptides MERCK PATENT GMBH (DE) 2010-01-19 US disclosed
US-20080164211-A1 Mixed-Modal Anion-Exchanged Type Separation Material MERCK PATENT GMBH (DE) 2008-07-10 US disclosed
EP-1817109-A1 MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL Merck Patent GmbH (DE) 2007-08-15 EP disclosed
WO-2006058623-A1 MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL MERCK PATENT GMBH (DE) 2006-06-08 WO disclosed